Spark Investment Management LLC Eiger Bio Pharmaceuticals, Inc. Transaction History

Spark Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 12, 2020	SELL	$5.4 - $13.37 $147,960 - $366,338	-27,400 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$4.91 - $14.7 $134,534 - $402,780	27,400 New	27,400 $186,000
Q3 2019 Nov 12, 2019	SELL	$9.59 - $12.0 $142,756 - $178,632	-14,886 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$9.54 - $14.96 $45,219 - $70,910	4,740 Added 46.72%	14,886 $157,000
Q4 2018 Feb 12, 2019	BUY	$8.63 - $12.4 $87,559 - $125,810	10,146 New	10,146 $103,000

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $418M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.